Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |